Compare SGML & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGML | TNDM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | 2013 |
| Metric | SGML | TNDM |
|---|---|---|
| Price | $5.82 | $16.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 25 |
| Target Price | $10.33 | ★ $27.76 |
| AVG Volume (30 Days) | ★ 2.7M | 2.1M |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $58.22 | $5.69 |
| Revenue Next Year | $138.88 | $12.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $4.99 | $12.26 |
| 52 Week High | $24.48 | $29.65 |
| Indicator | SGML | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 32.38 | 45.28 |
| Support Level | N/A | $14.66 |
| Resistance Level | $10.50 | $18.13 |
| Average True Range (ATR) | 0.63 | 1.13 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 21.95 | 33.02 |
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.